The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Cancer Chemotherapy and Pharmacology
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Signal integration by JNK and p38 MAPK pathways in cancer development
Wagner, E. F., & Nebreda, Á. R. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2694 · Cited by 2,586
Molecular targets of dietary agents for prevention and therapy of cancer
Aggarwal, B. B., & Shishodia, S. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.02.009 · Cited by 1,754
PI3K-Akt pathway: Its functions and alterations in human cancer
Osaki, M., Oshimura, M., & Ito, H. (2004) · Apoptosis · doi:10.1023/b:appt.0000045801.15585.dd · Cited by 1,264
Disruption of p53 in human cancer cells alters the responses to therapeutic agents.
Bunz, F., Hwang, P. M., Torrance, C., Waldman, T., Zhang, Y., Dillehay, L., Williams, J., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6863 · Cited by 1,044
Role of JNK activation in apoptosis: A double-edged sword
LIU, J., & LIN, A. (2005) · Cell Research · doi:10.1038/sj.cr.7290262 · Cited by 738
Cancer chemoprevention and chemotherapy: Dietary polyphenols and signalling pathways
Ramos, S. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700326 · Cited by 696
p38MAPK: stress responses from molecular mechanisms to therapeutics
Coulthard, L. R., White, D. E., Jones, D. L., McDermott, M. F., & Burchill, S. A. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.06.005 · Cited by 691
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance
McCubrey, J. A., Steelman, L. S., Abrams, S. L., Lee, J. T., Chang, F., Bertrand, F. E., Navolanic, P. M., Terrian, D. M., Franklin, R. A., D’Assoro, A. B., et al. (2006) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2006.01.004 · Cited by 664
Microsatellite instability in colorectal cancer
Söreide, K., Janssen, E. A. M., Söiland, H., Körner, H., & Baak, J. P. A. (2006) · British Journal of Surgery · doi:10.1002/bjs.5328 · Cited by 302
Itoh, N., Semba, S., Ito, M., Takeda, H., Kawata, S., & Yamakawa, M. (2002) · Cancer · doi:10.1002/cncr.10591 · Cited by 243
Jover, R., Zapater, P., Castells, A., Llor, X., Andreu, M., Cubiella, J., Piñol, V, Xicola, R. M., Bujanda, L., Reñé, J. M., et al. (2006) · Gut · doi:10.1136/gut.2005.073015 · Cited by 228
Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discovery
THOMPSON, N., & LYONS, J. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.04.007 · Cited by 214
Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines
Gayet, J., Zhou, X.-P., Duval, A., Rolland, S., Hoang, J.-M., Cottu, P., & Hamelin, R. (2001) · Oncogene · doi:10.1038/sj.onc.1204611 · Cited by 186
Natural products and colon cancer: current status and future prospects
Rajamanickam, S., & Agarwal, R. (2008) · Drug Development Research · doi:10.1002/ddr.20276 · Cited by 179
Xavier, C. P. R., Lima, C. F., Preto, A., Seruca, R., Fernandes-Ferreira, M., & Pereira-Wilson, C. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.041 · Cited by 176
Huerta, S., Goulet, E. J., & Livingston, E. H. (2006) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2005.11.009 · Cited by 158
Apoptosis signaling proteins as prognostic biomarkers in colorectal cancer: A review
Hector, S., & Prehn, J. H. M. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.12.002 · Cited by 132
Schiemann, U., Kellner, H., & Gross, M. (2004) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2004-812996 · Cited by 114
Mader, R. M., Müller, M., & Steger, G. G. (1998) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(98)00191-8 · Cited by 104
Colon cancer: genomics and apoptotic events
Rupnarain, C., Dlamini, Z., Naicker, S., & Bhoola, K. D. (2004) · Biological Chemistry · doi:10.1515/bc.2004.053 · Cited by 103
Benhattar, J., Cerottini, J., Saraga, E. P., Metthez, G., & Givel, J. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960621)69:3<190::aid-ijc7>3.0.co;2-v · Cited by 101
Shi, R., Huang, Q., Zhu, X., Ong, Y. B., Zhao, B., Lu, J., Ong, C. N., & Shen, H. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0638 · Cited by 101
Notoginseng enhances anti-cancer effect of 5-fluorouracil on human colorectal cancer cells
Wang, C., Luo, X., Zhang, B., Song, W.-X., Ni, M., Mehendale, S. R., Xie, J.-T., Aung, H. H., He, T., & Yuan, C.-S. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0350-2 · Cited by 93
Clinical implications of microsatellite instability in sporadic colon cancers
Sinicrope, F. A., & Sargent, D. J. (2009) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32832c94bd · Cited by 91
Adamsen, B. L., Kravik, K., Clausen, O. P. F., & Angelis, P. D. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.6.1491 · Cited by 60
The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancer
Warusavitarne, J. H., & Schnitzler, M. (2006) · International Journal of Colorectal Disease · doi:10.1007/s00384-006-0228-0 · Cited by 56
Synergistic effect of triptolide combined with 5-fluorouracil on colon carcinoma
Tang, X., Zhu, Y.-Q., Tao, W., Bai, W., & Lin, X. (2007) · Postgraduate Medical Journal · doi:10.1136/pgmj.2006.055426 · Cited by 47
First-line therapeutic strategies in metastatic colorectal cancer.
Davies, J. M., & Goldberg, R. M. (2008) · PubMed · Cited by 35
Mori, S., Ogata, Y., & Shirouzu, K. (2004) · International Journal of Clinical Oncology · doi:10.1007/s10147-004-0406-4 · Cited by 21
Bhushan, S., McLeod, H. L., & Walko, C. M. (2009) · Clinical Colorectal Cancer · doi:10.3816/ccc.2009.n.003 · Cited by 20
Cell death in response to antimetabolites directed at thymidylate synthase
Barbour, K. W., & Berger, F. G. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0461-4 · Cited by 11
Cited by
Mahapatro, A., & Singh, D. K. (2011) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-9-55 · Cited by 685
Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers
Popat, A., Hartono, S. B., Stahr, F., Liu, J., Qiao, S. Z., & Qing (Max) Lu, G. (2011) · Nanoscale · doi:10.1039/c1nr10224a · Cited by 548
Management of patients with adrenal cancer: recommendations of an international consensus conference
Schteingart, D. E., Doherty, G. M., Gauger, P. G., Giordano, T. J., Hammer, G. D., Korobkin, M., & Worden, F. P. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.01029 · Cited by 421
Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies
Smallridge, R. C., Marlow, L. A., & Copland, J. A. (2009) · Endocrine-Related Cancer · doi:10.1677/erc-08-0154 · Cited by 390
Oršolić, N. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9339-3 · Cited by 386
Metadata
- Venue
- Cancer Chemotherapy and Pharmacology
- Published
- 2013-05-24
- ISSN
- 0344-5704 (ISSN-L)
- 1432-0843
- OpenAlex
- W4236106489
- Cited by
- 430
- References
- 31
- Type
- paratext
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.